Frist Cressey Ventures Launches $425M Health Tech Fund with MedStar & OhioHealth

A new $425 million fund is poised to reshape healthcare delivery through strategic investments in early-stage health technology and artificial intelligence companies. Frist Cressey Ventures closed the oversubscribed fund on February 18, significantly expanding its capacity to influence innovation within the sector.

Strategic Partnerships Drive Investment

Frist Cressey Ventures is collaborating with health systems to identify and support promising new technologies. Columbia, Md.-based MedStar Health and Columbus-based OhioHealth are serving as both investors and collaborators in this venture. This approach aims to bridge the gap between technological development and real-world healthcare needs.

Health Systems Seek Innovation

MedStar Health views the partnership as a crucial opportunity to address complex challenges in healthcare. Bill Sheahan, senior vice president and chief innovation officer of MedStar Health and executive director of the MedStar Institute for Innovation, stated that Frist Cressey “helps us identify real innovations, and advises on where we should be spending our time, and capital.”

Did You Know? Frist Cressey Ventures now has almost $1 billion in total assets under management.

OhioHealth shares this perspective, emphasizing the value of Frist Cressey’s strategic guidance and investment performance. Jesse Longoria, senior vice president and chief strategy and growth officer of OhioHealth, noted that the collaboration will “help us see around corners and bring innovative opportunities to our organization.”

Implications for the Future

This funding could accelerate the development and adoption of new technologies within participating health systems. A possible next step is the identification of specific AI and health tech companies for investment. Analysts expect that this collaborative model may become more prevalent as health systems seek to proactively shape the future of care delivery.

Expert Insight: The direct involvement of health systems as both investors and collaborators represents a significant shift in venture capital within the healthcare space. This model allows for a more targeted approach to innovation, ensuring that investments align with the practical needs and strategic goals of the organizations providing care.

Further investment rounds and expansions of the partnership are also possible. It is likely to see increased focus on technologies that improve efficiency, enhance patient outcomes, and address critical gaps in healthcare services.

Frequently Asked Questions

What is the size of the new fund?

The new fund is $425 million.

Which health systems are partnering with Frist Cressey Ventures?

MedStar Health, based in Columbia, Md., and OhioHealth, based in Columbus, are partnering with Frist Cressey Ventures.

What types of companies will the fund invest in?

The fund will invest in early-stage health tech and AI companies.

How might these partnerships impact the future of healthcare innovation?